President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

International Business Machines said Monday it plans to invest $150 billion in the U.S. over the next five years, the latest ...

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins.

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...

Most major stock indexes across the globe moved upwards on a weekly basis, taking support from the uptick in US equities.

The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at ...

AbbVie is now pushing Skyrizi and Rinvoq to counter the drop in Humira sales and has forecast the two newer drugs to generate ...

Switzerland, as one of 15 countries, is engaged in 'privileged' negotiations with the US to mitigate impacts of new tariffs.

The Swiss president says Switzerland is among 15 countries with which the United States plans to conduct “privileged” negotiations to help reach a deal in the wake of sweeping U.S. tariffs on dozens o ...